'

DFNS.net CBRN News Blog

0

Report: Security Implication of the Nuclear Fuel Cycle

Report: New energy policies need to set a good example in terms of safeguards, transparency and restraint. The post Report: Security Implication of the Nuclear Fuel Cycle appeared first on James Martin Center for...

0

Resolving Key Nuclear Issue Turns on Iran-Russia Deal

By Gareth PorterWASHINGTON, Oct 28 2014 (IPS) U.S. and Iranian negotiators are working on a compromise approach to the issue of Iran’s uranium enrichment capabilities, which the Barack Obama administration has said in the...

0

ADI Offers Ebola ELISA Test Kits for Humans and Animals

Alpha Diagnostic Int’l (ADI) has announced availability of several rapid, and sensitive ELISA test kits for the detection of major Ebola viral protein antibodies including Glycoprotein (GP), Nucleoprotein (NP), and Viral Protein 40 (VP40)....

0

The Islamic State: Thoughts from the Top Think Tanks

By Erik Goepner Annually, the Think Tanks and Civil Societies Program (TTCSP) at the University of Pennsylvania publishes a ranking of the world’s think tanks. Regarding the Islamic State and the coalition’s response, perspectives...

0

Battelle Wins CBRNE Contract from CENTCOM

Experts from Battelle will now provide on-site support at U.S. Central Command (CENTOM) headquarters at MacDill Air Force Base in Tampa, Fl., helping in their critical mission to Counter Weapons of Mass Destruction and...

0

Blackmailers threaten Czechs with Ebola outbreak

AFP – Blackmailers are threatening to spread Ebola in the Czech Republic unless Prague pays them a million euros’ worth of the virtual Bitcoin currency, police said Monday. An e-mail allegedly from the blackmailers...

0

New Hope for Drug Discovery in African Sleeping Sickness

In early drug discovery, you need a starting point, says Northeastern University associate professor of chemistry and chemical biology Michael Pollastri. In a new research paper recently published the journal PLOS Neglected Tropical Diseases,...

0

Shorter TB Treatment Not A Successful Alternative

A clinical drug trial conducted in five Sub-Sahara African countries shows that a shortened (four month) treatment for tuberculosis (TB) is well tolerated and may work well in subsets of TB patients, but overall...

0

FDA Clears BioFire Ebola Diagnostics for Emergency Use

The U.S. Food and Drug Administration (FDA) has authorized emergency use of two BioFire Defense diagnostic tests to detect the Ebola Zaire virus in individuals with signs and symptoms of Ebola virus infection, or...

0

DARPA Awards 12.2M for Monoclonal Antibody Research

Inovio Pharmaceuticals, Inc. has been awarded $12.2 million by the Defense Advanced Research Projects Agency (DARPA) for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the...

0

Johns Hopkins to Develop National Ebola Training

Johns Hopkins Medicine has been tasked by the Centers for Disease Control and Prevention (CDC) to lead the effort to design an interactive Web-based learning program that guides health care workers, nurses and physicians...

0

Week in DC: Events

October 27, 2014 Ebola: U.S. Domestic and Foreign Policy Options Date: October 27, 12:00pm Location: Heritage Foundation, 214 Massachusetts Ave, NE, Lehrman Auditorium, Washington DC Months after the outbreak of the Ebola virus in...

0

NCT CBRNe Asia 2014 – #1 CBRNe event in Asia

NCT CBRNe Asia Event Series 2012-2014 During the last three years, NCT CBRNe Asia has become the largest and leading forum in the field of CBRN defense in Asia. It has welcomed CBRN Defense...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close